Form 4 for IMNM Immunome Inc.
Accepted 2026-06-29 16:52:50 ET · period of report 2026-06-25 · accession 0001997584-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-29 16:52 | 2026-06-25 | IMNM | Lechleider Robert | Chief Medical Off | M - OptEx | $8.73 | +55.0K | 70.8K | +348% | +$480.1K |
| DMT | 2026-06-29 16:52 | 2026-06-25 | IMNM | Lechleider Robert | Chief Medical Off | S - Sale+OE | $19.85 | -55.0K | 15.8K | -78% | -$1.09M |
| DT | 2026-06-29 16:52 | 2026-06-25 | IMNM | Lechleider Robert | Chief Medical Off | M - OptEx | $0.00 | -55.0K | 345.0K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-25 | M | A | 55,000 | $8.73 | 70,805 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-25 | S | D | 40,580 | $19.56 | 30,225 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026. (F2) The weighted average sale price for the transaction report was $19.56, and the range of prices were between $19.27 and $20.255, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2026-06-25 | S | D | 14,420 | $20.66 | 15,805 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026. (F3) The weighted average sale price for the transaction report was $20.66, and the range of prices were between $20.275 and $21.02, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2026-06-25 | M | D | 55,000 | $0.00 | 345,000 | D | $8.73 · — to 2033-10-26 | 55,000 Common Stock | (F4) 25% of the shares subject to the option vested on October 16, 2024, and the remaining shares will vest monthly thereafter over three years. |